HighTower Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

HighTower Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,730	Closed	-$200K	–	2193
2016 Q1	$200K	Sell	3,730 -7	-0.2%	-$517	﹤0.01%	1809
2015 Q4	$420K	Buy	+3,737	New	+$412K	0.01%	1410

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

HighTower Advisors's ANAC Position: Q2 2016 in Review

HighTower Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 3,730 shares — an estimated $200K sold.

HighTower Advisors first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $420K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

HighTower Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
HighTower Advisors sold 3,730 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $200K.
HighTower Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
HighTower Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $420K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on HighTower Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.